XML 37 R25.htm IDEA: XBRL DOCUMENT
v3.25.2

NET LOSS PER SHARE (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2025
Earnings Per Share [Abstract] |
Summary of Antidilutive Securities | The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:
| Three and Six Months Ended June 30,
| 2025 |  | 2024
Public warrants | 500,000 |  |  | 500,000 |
Private warrants | 13,300 |  |  | 13,300 |
Stock options | 270,554 |  |  | 332,468 |
Unvested restricted stock units | 187,744 |  |  | 312,166 |
Total common stock equivalents | 971,598 |  |  | 1,157,934 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration